A Rutgers research team has completed the first evaluation of a new rapid COVID-19 test given emergency approval by the FDA. The test, developed by CEPHEID, a U.S. molecular diagnostics company, is fast and easy to perform without the need for a centralized...
UCSF is using the Eureka Mobile Research Platform—an NIH funded digital research platform—to launch a world-wide study to track COVID-19 symptoms, infections, risk factors and behaviors that might impact transmission. The study, called the COVID-19 Citizen Science...
As international experts elevate warnings about the spread of the coronavirus, NJTV News reports Rutgers researchers from the Protein Data Bank might have found the key to fighting it. To learn more.
